Chart: Council Highlights Priority Areas
This article was originally published in The Gray Sheet
You may also be interested in...
"Plug And Play" Medical Systems Raise Complicated Regulatory Questions
FDA, device makers and others are struggling to identify the best way to regulate "interoperable" medical systems - such as an iPhone that receives blood glucose data - with some suggesting that a separate classification scheme might be needed
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.